ImmunoCellular Therapeutics Announces First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/30/2026
- Wall Street ends higher as US, Iran attacks ease; major tech-related shares jump
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
ImmunoCellular Therapeutics (IMUC) Tops Q1 EPS by 1c
May 12, 2016 4:59 PM EDTImmunoCellular Therapeutics (NYSE: IMUC) reported Q1 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.
... More